EpiVario Inc.

Pharmaceutical company · Philadelphia, Pennsylvania, United States

EpiVario Inc. is a pharmaceutical company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2017. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $830,549 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $125,000 sold in a notice filed in 2024.

Http://Www.epivario.comProfile compiled from public records. Is this your company? Request a correction or update

EpiVario at a glance

Typepharmaceutical company
HeadquartersPhiladelphia, Pennsylvania, United States
Earliest incorporation on record2017
Employees (self-reported, 2024)2
SEC CIK1753351

What does EpiVario do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $830,549 in total (2022 to 2024). NIH funding came from the National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism.

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $125,000 sold (2024).

Frequently asked questions about EpiVario

Where is EpiVario headquartered?

EpiVario Inc. is headquartered in Philadelphia, Pennsylvania, United States.

What does EpiVario do?

EpiVario Inc. is a pharmaceutical company.

When was EpiVario founded?

The earliest incorporation on record for EpiVario Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences